Published in Autism Res on April 29, 2011
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry (2013) 1.93
Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism. Biol Psychiatry (2013) 1.21
Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology (2011) 0.94
Influence of prenatal iron deficiency and MAOA genotype on response to social challenge in rhesus monkey infants. Genes Brain Behav (2012) 0.87
Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients. ScientificWorldJournal (2013) 0.80
Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. Hum Mol Genet (2015) 0.79
Age dependent forebrain structural changes in mice deficient in the autism associated gene Met tyrosine kinase. Neuroimage Clin (2012) 0.78
Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine. Neuropharmacology (2016) 0.77
Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome. J Neurodev Disord (2014) 0.77
Autism Spectrum Disorder in Males with Sex Chromosome Aneuploidy: XXY/Klinefelter Syndrome, XYY, and XXYY. J Dev Behav Pediatr (2017) 0.75
Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome. Brain Dev (2017) 0.75
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord (2000) 37.47
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med (1995) 12.70
Prevalence of autism in a US metropolitan area. JAMA (2003) 10.37
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry (2010) 4.92
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ (2007) 4.70
A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry (2010) 4.10
A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry (1989) 4.04
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci (2003) 3.79
The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry (2006) 3.63
A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 3.59
The prevalence of autism. JAMA (2003) 3.57
A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann Hum Genet (2009) 2.15
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron (1996) 1.96
Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am J Psychiatry (1985) 1.95
The serotonin system in autism. Curr Opin Pediatr (1996) 1.77
Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71
Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev (2009) 1.71
Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. Ups J Med Sci (2010) 1.67
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
Regression in autism: prevalence and associated factors in the CHARGE Study. Ambul Pediatr (2008) 1.56
MAOA and the neurogenetic architecture of human aggression. Trends Neurosci (2008) 1.55
A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry (2000) 1.44
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry (2010) 1.40
Language and other regression: assessment and timing. J Autism Dev Disord (2003) 1.40
Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin Neurosci (2009) 1.39
Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry (1987) 1.35
Autism: recent molecular genetic advances. Hum Mol Genet (2000) 1.34
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet (2001) 1.28
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2010) 1.23
Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet (1997) 1.21
Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry (2009) 1.19
Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry (1977) 1.15
Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry (2002) 1.14
Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord (1991) 1.14
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry (1999) 1.14
Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet (1999) 1.14
A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry (1993) 1.13
Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet (2003) 1.11
Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders. Am J Med Genet (2001) 1.04
Language regression in childhood. Pediatr Neurol (2001) 1.02
Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res (2004) 1.02
Association of autistic-like and internalizing traits during childhood: a longitudinal twin study. Am J Psychiatry (2010) 1.01
The hyperserotonemia of autism. Ann N Y Acad Sci (1990) 1.01
Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry (2002) 1.00
Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Cancer Epidemiol Biomarkers Prev (2007) 0.97
Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci (1990) 0.96
Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry (2006) 0.95
Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders. Prog Brain Res (2008) 0.94
Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord (2008) 0.94
Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet (2000) 0.93
Three autism candidate genes: a synthesis of human genetic analysis with other disciplines. Int J Dev Neurosci (2005) 0.93
Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry (1996) 0.92
Autism severity is associated with child and maternal MAOA genotypes. Clin Genet (2011) 0.91
Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci Res (2008) 0.88
Developmental maturation of excitation and inhibition balance in principal neurons across four layers of somatosensory cortex. Neuroscience (2010) 0.88
Monoamine oxidases A and B gene polymorphisms in migraine patients. J Neurol Sci (2004) 0.87
The molecular genetics of autism. Curr Psychiatry Rep (2000) 0.86
Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.85
Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet (2002) 0.84
Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet B Neuropsychiatr Genet (2004) 0.84
Hyperserotonemia in autism: the potential role of 5HT-related gene variants. Coll Antropol (2008) 0.84
Serotonin transporter promoter variants: Analysis in Indian autistic and control population. Brain Res (2006) 0.82
MAOA-uVNTR polymorphism may modify the protective effect of ALDH2 gene against alcohol dependence in antisocial personality disorder. Alcohol Clin Exp Res (2009) 0.81
Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. Am J Intellect Dev Disabil (2009) 0.80
Estimating the accuracy of psychological scales using longitudinal data. Biostatistics (2003) 0.78
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible? Can J Psychiatry (2000) 0.76
Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. J Child Adolesc Psychopharmacol (2002) 0.76
Autism and associated behavioral disorders: pharmacotherapeutic intervention. Ann Pharmacother (1995) 0.76
Inhibition of monoamine oxidase-A of rat brain by pyrethroids--an in vitro kinetic study. Mol Cell Biochem (1993) 0.76
Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet (2008) 6.42
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology (2011) 3.15
Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol (2009) 2.77
Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. J Natl Cancer Inst (2013) 2.45
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect (2003) 2.41
Arsenic exposure from drinking water and birth weight. Epidemiology (2003) 2.32
Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health (2003) 2.27
Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry (2013) 2.24
Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics (2012) 2.18
Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke (2010) 2.18
Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr (2012) 2.14
Mitochondrial dysfunction in autism. JAMA (2010) 2.04
Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J (2005) 1.97
Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology (2006) 1.97
Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet (2010) 1.95
Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect (2010) 1.92
The faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol (2008) 1.91
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (2008) 1.89
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem (2010) 1.86
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect (2008) 1.82
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol (2009) 1.77
Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res (2008) 1.72
Indoor coal use and early childhood growth. Arch Pediatr Adolesc Med (2011) 1.71
Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci (2007) 1.68
Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol (2003) 1.68
NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release. Circ Res (2003) 1.67
Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev (2002) 1.62
Psychosocial factors and preterm birth among African American and White women in central North Carolina. Am J Public Health (2004) 1.60
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation. Immunol Cell Biol (2013) 1.60
Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U S A (2009) 1.57
Regression in autism: prevalence and associated factors in the CHARGE Study. Ambul Pediatr (2008) 1.56
Gene expression changes in children with autism. Genomics (2007) 1.55
Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol (2008) 1.55
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ Health Perspect (2014) 1.54
The onset of autism: patterns of symptom emergence in the first years of life. Autism Res (2008) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci U S A (2004) 1.51
Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect (2016) 1.50
The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry. J Gen Physiol (2009) 1.50
Determinants of serum polychlorinated biphenyls and organochlorine pesticides measured in women from the child health and development study cohort, 1963-1967. Environ Health Perspect (2002) 1.50
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol (2010) 1.46
Research priorities for developmental-behavioral pediatrics: a DBPNet consensus study. J Dev Behav Pediatr (2012) 1.43
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem (2003) 1.38
PBDEs in 2-5 year-old children from California and associations with diet and indoor environment. Environ Sci Technol (2010) 1.38
Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. Biostatistics (2006) 1.38
Heat shock proteins: cellular and molecular mechanisms in the central nervous system. Prog Neurobiol (2010) 1.37
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res (2008) 1.37
Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol (2014) 1.36
Conditions for bias from differential left truncation. Am J Epidemiol (2006) 1.35
Polychlorinated biphenyls and their hydroxylated metabolites (OH-PCBS) in pregnant women from eastern Slovakia. Environ Health Perspect (2007) 1.35
Gene-environment interplay in common complex diseases: forging an integrative model—recommendations from an NIH workshop. Genet Epidemiol (2011) 1.33
Formulation and characterization of an experimental PCB mixture designed to mimic human exposure from contaminated fish. Toxicol Sci (2005) 1.32
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect (2008) 1.27
Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord (2014) 1.26
Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord (2013) 1.25
Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J Biol Chem (2007) 1.25
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect (2012) 1.25
Associations of abdominal fat with perceived racism and passive emotional responses to racism in African American women. Am J Public Health (2007) 1.24
Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Hum Mol Genet (2010) 1.24
Global increases in both common and rare copy number load associated with autism. Hum Mol Genet (2013) 1.24
Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J Biol Chem (2006) 1.23
Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem (2007) 1.22
Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells. J Biol Chem (2003) 1.22
Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism. Biol Psychiatry (2013) 1.21
Month of conception and risk of autism. Epidemiology (2011) 1.21
Social correlates of the chronic stress of perceived racism among Black women. Ethn Dis (2006) 1.20
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet (2012) 1.19